Back
Enphase Energy Vs. Kymera Therapeutics Industry Stock Comparison
Buy
54
ENPH
Enphase Energy
Last Price:
116.36
Seasonality Move:
2.71%
Buy
67
KYMR
Kymera Therapeutics
Last Price:
43.81
Seasonality Move:
-6.51%
Buy
54
Enphase Energy (ENPH)
is a Buy
Is Enphase Energy a Buy, Sell or Hold?
- The current Enphase Energy [ENPH] share price is $116.39. The Score for ENPH is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ENPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $43.80. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ENPH Stock Price Chart
What is Enphase Energy's stock price today?
-
The Enphase Energy share price today is $116.39
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENPH is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $43.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
ENPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.7 | Buy |
| Relative Strength Index (14 RSI): | 56.82 | Buy |
| Chaikin Money Flow: | -152906 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (105.28 - 115.54) | Buy |
| Bollinger Bands (100): | (105.1 - 122.54) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.08 | Buy |
| Relative Strength Index (14 RSI): | 56.59 | Buy |
| Chaikin Money Flow: | -25430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.48 - 45.3) | Buy |
| Bollinger Bands (100): | (32.4 - 41.52) | Buy |
ENPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.8 | Buy |
| 20-day SMA: | 110.33 | Buy |
| 50-day SMA: | 111.47 | Buy |
| 200-day SMA: | 112.44 | Buy |
| 8-day EMA: | 112.2 | Buy |
| 20-day EMA: | 110.59 | Buy |
| 50-day EMA: | 111.44 | Buy |
| 200-day EMA: | 120.11 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.47 | Buy |
| 20-day SMA: | 42.87 | Buy |
| 50-day SMA: | 38.23 | Buy |
| 200-day SMA: | 33.07 | Buy |
| 8-day EMA: | 42.93 | Buy |
| 20-day EMA: | 42.2 | Buy |
| 50-day EMA: | 39.81 | Buy |
| 200-day EMA: | 34.21 | Buy |
Enphase Energy Earnings Growth & ENPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.20 per share, an increase next quarter of $0.47 per share, a decrease this year of $1.82 per share, and an increase next year of $2.28 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.38 per share.
Enphase Energy Technical Analysis
| Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||